These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30417253)

  • 1. A systematic review of factors affecting medication adherence among patients with osteoporosis.
    Yeam CT; Chia S; Tan HCC; Kwan YH; Fong W; Seng JJB
    Osteoporos Int; 2018 Dec; 29(12):2623-2637. PubMed ID: 30417253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature.
    Seng JJB; Tan JY; Yeam CT; Htay H; Foo WYM
    Int Urol Nephrol; 2020 May; 52(5):903-916. PubMed ID: 32236780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review.
    Fatoye F; Smith P; Gebrye T; Yeowell G
    BMJ Open; 2019 Apr; 9(4):e027049. PubMed ID: 30987990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients.
    Morizio P; Burkhart JI; Ozawa S
    Ann Pharmacother; 2018 Oct; 52(10):1031-1041. PubMed ID: 29616561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men.
    Mikyas Y; Agodoa I; Yurgin N
    Appl Health Econ Health Policy; 2014 Jun; 12(3):267-77. PubMed ID: 24477429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' first-year adherence to different anti-osteoporotic therapy after hip fractures.
    Kim SJ; Cho YJ; Lee DW
    Injury; 2021 Jun; 52(6):1506-1510. PubMed ID: 33223260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
    Reyes C; Tebe C; Martinez-Laguna D; Ali MS; Soria-Castro A; Carbonell C; Prieto-Alhambra D
    Osteoporos Int; 2017 Oct; 28(10):2997-3004. PubMed ID: 28714038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Belhassen M; Confavreux CB; Cortet B; Lamezec L; Ginoux M; Van Ganse E
    Osteoporos Int; 2017 Mar; 28(3):853-862. PubMed ID: 27766368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates.
    Goldshtein I; Rouach V; Shamir-Stein N; Yu J; Chodick G
    Adv Ther; 2016 Aug; 33(8):1374-84. PubMed ID: 27329383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    McAlister FA; Ye C; Beaupre LA; Rowe BH; Johnson JA; Bellerose D; Hassan I; Majumdar SR
    Osteoporos Int; 2019 Jan; 30(1):127-134. PubMed ID: 30232538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis.
    Imaz I; Zegarra P; González-Enríquez J; Rubio B; Alcazar R; Amate JM
    Osteoporos Int; 2010 Nov; 21(11):1943-51. PubMed ID: 19967338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-osteoporotic therapy in Denmark--predictors and demographics of poor refill compliance and poor persistence.
    Hansen C; Pedersen BD; Konradsen H; Abrahamsen B
    Osteoporos Int; 2013 Jul; 24(7):2079-97. PubMed ID: 23179576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy.
    Iglay K; Cao X; Mavros P; Joshi K; Yu S; Tunceli K
    Clin Ther; 2015 Aug; 37(8):1813-21.e1. PubMed ID: 26117406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
    Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis.
    Kothawala P; Badamgarav E; Ryu S; Miller RM; Halbert RJ
    Mayo Clin Proc; 2007 Dec; 82(12):1493-501. PubMed ID: 18053457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.
    Hiligsmann M; Salas M; Hughes DA; Manias E; Gwadry-Sridhar FH; Linck P; Cowell W
    Osteoporos Int; 2013 Dec; 24(12):2907-18. PubMed ID: 23636230
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.